Navigation Links
Accuray Incorporated to Report Financial Results for Second Quarter Fiscal 2013
Date:1/17/2013

SUNNYVALE, Calif., Jan. 17, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that it will report results for its second quarter of fiscal 2013, ended December 31, 2012 on Wednesday, February 6, 2013 after the market closes.

A conference call to review the results will begin at 2:00 p.m. PST/5:00 p.m. EST and will be hosted by Joshua H. Levine , president and chief executive officer and Derek Bertocci , senior vice president and chief financial officer.

The conference call dial-in numbers are 1-866-761-0749 (USA) or 1-617-614-2707 (International), Conference ID: 63591669. In addition, a dial-up replay of the conference call will be available beginning February 6, 2013 at 5:00 p.m. PST/8:00 p.m. EST and ending on February 13, 2013. The replay telephone number is 1-888-286-8010 (USA) or 1-617-801-6888 (International), Conference ID:  63531003.

A live webcast of the call will also be available from the Investor Relations section of the corporate website at http://www.accuray.com/investors.  A webcast replay can be accessed on the corporate website beginning Wednesday, February 6, 2013 at approximately 5:00 p.m. PST/8:00 p.m. EST.  The replay will remain available until Accuray announces its results for the third quarter of fiscal 2013, ending March 31, 2013.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), is a radiation oncology company that develops, manufactures and sells personalized, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com.

Contacts:

Investor Contact:

Tom Rathjen

Vice President, Investor Relations

+1 (408) 789-4458

trathjen@accuray.com

Media Contact:

Stephanie Tomei

Director, Corporate Communications

+1 (408) 789-4234

stomei@accuray.com


'/>"/>
SOURCE Accuray Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Accuray Incorporated to Speak at 23rd Annual Oppenheimer Healthcare Conference
2. Accuray Incorporated to Speak at 24th Annual Piper Jaffray Healthcare Conference
3. Accuray Incorporated to Speak at Lazard Capital Markets Healthcare Conference
4. 90 Presentations at Leading Radiation Oncology Meeting Demonstrate the Breadth and Depth of Clinical Evidence for Accuray Technologies
5. Accuray Announces Results for Fourth Quarter and Fiscal Year 2012
6. Accuray Incorporateds CEO to Speak at Morgan Stanley Global Healthcare Conference
7. Accuray to Acquire Morphormics, Inc.
8. Accuray and Erasmus Medical Center Sign Master Research and Collaboration Agreement
9. One Year After TomoTherapy Acquisition, Accuray on Track to Meet or Exceed Integration Success Metrics And Expecting Near-term Return to Profitability
10. Accuray Rolls Out Comprehensive Customer Service Program in Japan
11. Accuray Incorporated to Speak at Wells Fargo Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... May 27, 2016 Amarantus BioScience Holdings, ... developing products for Regenerative Medicine, Neurology and Orphan Diseases, today announced ... presenting at two upcoming investor conferences: SeeThru Equity ... Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand Hyatt Hotel, ...
(Date:5/26/2016)... , May 26, 2016 ... With Both Cost Savings and Overall Decreased ... (LSE: BTG), an international specialist healthcare company, has ... the 21st Annual Meeting of ISPOR (International Society ... of hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres ...
(Date:5/25/2016)... -- According to a new market research ... by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by Application (Drug ... Hospitals/ Clinics) - Forecast to 2021", published by MarketsandMarkets, ... the forecast period of 2016 to 2021. This market ... from USD 117.3 Million in 2016, at a CAGR ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... ... ... Connor Sports, through its Connor Cares initiative, will continue to expand ... Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and final WNBA ... levels of the game, Connor Sports has committed to a significantly increased focus on ...
(Date:5/26/2016)... ... ... MadgeTech will be showcasing its line of data logging products , ... MadgeTech headquarters. With products sold in more than 100 countries around the world, MadgeTech ... , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech data loggers around ...
Breaking Medicine News(10 mins):